SFX by Ex Libris Inc.

Title:	Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia
Source:	Nature [0028-0836] Jumaa, Hassan yr:2003

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Schwartzberg, Pamela L L. "Amplifying Btk's signal." Immunity 19.5 (2003): 634-636.
description	2.	Jumaa, H. "The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage." European journal of immunology 31.7 (2001): 2164-9.
description	3.	Tiribelli, M. "Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib." Leukemia Research 33.1 (2009): 174-177.
description	4.	Saito, K. "BTK Regulates PtdIns-4, 5-P2 Synthesis Importance for Calcium Signaling and PI3K Activity." Immunity 19.5 (2003): 669-78.
description	5.	Kantarjian, Hagop M. "Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia." Cancer 121.23 (2015): 4158-4164.
description	6.	Castellino, A M M. "A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase." The Journal of biological chemistry 272.9 (1997): 5861-5870.
description	7.	Maury, S. "Searching for factors to improve the antileukemic effect of donor lymphocyte infusion." Blood 111.10 (2008): 5256-7.
description	8.	Michel, G. "First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: Results of the Cooprall-97 study." European journal of cancer 44.16 (2008): 2461-2469.
description	9.	Lee, Hun J. "Philadelphia chromosome-positive acute lymphoblastic leukemia." Cancer 117.8 (2011): 1583-1594.
description	10.	Paz, A. "Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation." Oncogene 20.51 (2001): 7486-7493.
description	11.	Ye, M. "Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential." Immunity 19.5 (2003): 689-699.
description	12.	Zhang, H. "Loss of Tsc1/Tsc2 activates mTOR and disrupts P13K-Akt signaling through downregulation of PDGFR." The journal of clinical investigation 112.8 (2003): 1223-1233.
description	13.	Park, Chan Young Y. "Cell signaling. The double life of a transcription factor takes it outside the nucleus." Science 314.5796 (2006): 64-5.
description	14.	Oude Weernink, Paschal A A. "Regulation and cellular roles of phosphoinositide 5-kinases." European journal of pharmacology 500.1-3 (2004): 87-99.
description	15.	Jacola, Lisa M. "Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol." Journal of clinical oncology 34.11 (2016): 1239-1247.
description	16.	Jabbour, E. "Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study." Lancet oncology 16.15 (2015): 1547-55.
description	17.	Kantarjian, H. "First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia." Blood 116.12 (2010): 2070-7.
description	18.	Dilloo, D. "Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia." Haematologica 92.8 (2007): 1043-50.
description	19.	Inaba, H. "Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis." Cancer 113.3 (2008): 522-9.
description	20.	Deeg, H Joachim J. "Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia." Biology of blood and marrow transplantation 16.4: 713-720.